<SEC-DOCUMENT>0001213900-23-047063.txt : 20230607
<SEC-HEADER>0001213900-23-047063.hdr.sgml : 20230607
<ACCEPTANCE-DATETIME>20230607104814
ACCESSION NUMBER:		0001213900-23-047063
CONFORMED SUBMISSION TYPE:	S-1/A
PUBLIC DOCUMENT COUNT:		17
FILED AS OF DATE:		20230607
DATE AS OF CHANGE:		20230607

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ABVC BIOPHARMA, INC.
		CENTRAL INDEX KEY:			0001173313
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				260014658
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-1/A
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-271416
		FILM NUMBER:		23998071

	BUSINESS ADDRESS:	
		STREET 1:		44370 OLD WARM SPRINGS BLVD.
		CITY:			FREMONT
		STATE:			CA
		ZIP:			94538
		BUSINESS PHONE:		510-668-0881

	MAIL ADDRESS:	
		STREET 1:		44370 OLD WARM SPRINGS BLVD.
		CITY:			FREMONT
		STATE:			CA
		ZIP:			94538

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	American BriVision (Holding) Corp
		DATE OF NAME CHANGE:	20160111

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	METU BRANDS, INC.
		DATE OF NAME CHANGE:	20150908

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ECOLOGY COATINGS, INC.
		DATE OF NAME CHANGE:	20080821
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-1/A
<SEQUENCE>1
<FILENAME>ea179866-s1a3_abvcbio.htm
<DESCRIPTION>AMENDMENT NO. 3 TO FORM S-1
<TEXT>
<XBRL>
<?xml version="1.0" encoding="ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Wed Jun 07 12:51:52 UTC 2023 -->
<html xmlns:abvc="http://metuboutique.com/20221231" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:compsci="http://compsciresources.com" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/1999/xhtml">
<head>
     <title> </title>

<meta content="text/html" http-equiv="Content-Type" />
</head>
<body><div style="font: 10pt Times New Roman, Times, Serif"><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>As filed with the Securities and Exchange Commission
on June 7, 2023</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><b>Registration No. 333-271416</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Washington, D.C. 20549</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PRE-EFFECTIVE AMENDMENT NO. 3 TO</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <span style="-sec-ix-hidden: hidden-fact-0">S-1</span> </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>REGISTRATION STATEMENT</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><i>UNDER</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><i>THE SECURITIES ACT OF 1933</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><ix:nonNumeric contextRef="c0" name="dei:EntityRegistrantName"><b>ABVC BIOPHARMA, INC.</b></ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Exact name of registrant as specified in its
charter)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr> <td style="vertical-align: top; width: 32%; border-bottom: black 1.5pt solid; text-align: center"><ix:nonNumeric contextRef="c0" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode"><span style="font-size: 10pt"><b>Nevada</b></span></ix:nonNumeric></td> <td style="vertical-align: bottom; width: 2%; text-align: center">&#160;</td> <td style="vertical-align: top; width: 32%; border-bottom: black 1.5pt solid; text-align: center"><span style="font-size: 10pt"><b>5084</b></span></td> <td style="vertical-align: bottom; width: 2%; text-align: center">&#160;</td> <td style="vertical-align: top; width: 32%; border-bottom: black 1.5pt solid; text-align: center"><span style="font-size: 10pt"><b>26-0014658</b></span></td></tr> <tr> <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt"><b>(State or other jurisdiction of<br/> incorporation or organization)</b></span></td> <td style="vertical-align: bottom; text-align: center">&#160;</td> <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt"><b>(Primary Standard Industrial<br/> Classification Code Number)</b></span></td> <td style="vertical-align: bottom; text-align: center">&#160;</td> <td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(I.R.S. Employer<br/> Identification Number)</b></p></td></tr> </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>44370 Old Warm Springs Blvd., </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Fremont, CA 94538</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(510) 668-0881</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Address, including zip code, and telephone
number, including area code, of registrant&#8217;s principal executive offices) </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Dr. Howard Doong</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Chief Executive Officer </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>44370 Old Warm Springs Blvd., </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Fremont, CA 94538</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(510) 668-0881- telephone</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Name, address, including zip code, and telephone
number, including area code, of agent for service) </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><i>With copies to:</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>Louis Taubman, Esq.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>Joan Wu, Esq.</b></p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><b>Hunter
Taubman Fischer &amp; Li LLC</b></span></p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><b>950
Third Avenue, 19th Floor</b></span></p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><b>New
York, New York &#8204;10022</b></span></p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><b>(917)
512-0827- telephone</b></span></p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><b>Louis
Taubman, Esq.</b></span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Approximate date of commencement of proposed
sale of the securities to the public: </b>As soon as practicable after this registration statement is declared effective.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If any of the securities being registered on
this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following
box. <span style="font-family: Times New Roman, Times, Serif">&#9746;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If this Form is filed to register additional
securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act
registration statement number of the earlier effective registration statement for the same offering. <span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If this Form is a post-effective amendment filed
pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of
the earlier effective registration statement for the same offering. <span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If this Form is a post-effective amendment filed
pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of
the earlier effective registration statement for the same offering. <span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company.
See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company&#8221;
and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 25%"><span style="font-size: 10pt">Large accelerated filer </span></td> <td style="width: 25%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td> <td style="width: 25%"><span style="font-size: 10pt">Accelerated filer </span></td> <td style="width: 25%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td> </tr> <tr style="vertical-align: top"> <td><span style="font-size: 10pt"><ix:nonNumeric contextRef="c0" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory">Non-accelerated filer</ix:nonNumeric> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</span></td> <td><span style="font-size: 10pt">Smaller reporting company </span></td> <td><ix:nonNumeric contextRef="c0" format="ixt:fixed-true" name="dei:EntitySmallBusiness"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</span></ix:nonNumeric></td> </tr> <tr style="vertical-align: top"> <td>&#160;</td> <td>&#160;</td> <td><span style="font-size: 10pt">Emerging growth company </span></td> <td><ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:EntityEmergingGrowthCompany"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></ix:nonNumeric></td> </tr> </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. <span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>The Registrant hereby amends this registration
statement on such date or dates as may be necessary to delay its effective date until the Registrant shall file a further amendment that
specifically states that this registration statement shall thereafter become effective in accordance with Section 8(a) of the Securities
Act of 1933, as amended, or until the registration statement shall become effective on such date as the Securities and Exchange Commission,
acting pursuant to said Section 8(a), may determine.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin: 0pt">&#160;</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>EXPLANATORY NOTE</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_AmendmentDescription-c0_cont_1" name="dei:AmendmentDescription"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ABVC BioPharma, Inc. is filing this Amendment
No. 3 (this &#8220;Amendment No. 3&#8221;) to the Registration Statement on Form F-1 (Registration No. 333-271416), originally filed
on April 24, 2023 and amended on May 10, 2023 and June 1, 2023 (as amended, the &#8220;Registration Statement&#8221;), <span>as
an exhibits-only filing to provide an updated auditor consent as Exhibit 23.2. Accordingly, this amendment consists only of the facing
page, this explanatory note, Item 16(a) of Part II of the Registration Statement, the signature page to the Registration Statement and
the filed exhibits. The remainder of the Registration Statement is unchanged and has therefore been omitted.</span></p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><ix:continuation id="_AmendmentDescription-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">No additional securities are being registered
under this Pre-Effective Amendment No. 3. All applicable registration fees were previously paid.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>


</div><!-- Field: Page; Sequence: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin: 0pt">&#160;</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PART II &#8212; INFORMATION NOT REQUIRED IN
PROSPECTUS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 16. <i>Exhibits and Financial Statement
Schedules </i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="border-bottom: black 1.5pt solid; vertical-align: top; width: 9%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit
    No.</b></span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; width: 90%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1 </span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1173313/000101489716000457/exhibit101.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share
    Exchange Agreement, dated February 8, 2016 (1)</span></a></td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1173313/000113789202000063/fex301ai.txt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Articles
    of Incorporation of the Company (2)</span></a></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1173313/000121390023025554/f10k2022ex3-2_abvcbiopharma.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bylaws
    of the Company, as amended (3)</span></a></td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1173313/000161577416004635/s102891_4-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certificate
    of Amendment to Articles of Incorporation filed on March 21, 2016 (4)</span></a></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1173313/000161577416007154/s104086_ex3-4.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certificate
    of Amendment to Articles of Incorporation filed on December 30, 2015 (5)</span></a></td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.5</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1173313/000121390020008785/ea120454ex3-1_americanbri.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certificate
    of Amendment to Articles of Incorporation filed on March 30, 2020 (6)</span></a></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.6</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1173313/000121390021025389/f10q0321ex3-6_abvcbio.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certificate
    of Amendment to Articles of Incorporation filed on February 17, 2021 (10)</span></a></td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1173313/000121390020010040/ea121013ex4-1_american.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
    of Warrant (7)</span></a></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8204;<a href="http://www.sec.gov/Archives/edgar/data/1173313/000121390022032864/ea158528ex4-2_abvcbio.htm">Form
    of the Registrant&#8217;s Common Stock certificate &#8204;(16)</a></span></td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1173313/000121390023032016/ea177310ex5-1_abvcbio.htm">Legal
    Opinion of Hunter Taubman Fischer &amp; Li LLC (27)</a></span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1173313/000101489716000457/exhibit102.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Collaboration
    Agreement dated December 29, 2015 (8)</span></a></td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1173313/000161577416005823/s103448_ex99-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Collaborative
    Agreement and Milestone Payment Agreement dated May 6, 2016 (9)</span></a></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8204;10.3</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1173313/000121390017001707/f8k0217ex99i_americanbri.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Addendum
    to the Collaboration Agreement dated January 12, 2017 (11)</span></a></td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8204;10.4</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1173313/000121390017007869/f8k072417ex10i_americanbri.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Collaboration
    Agreement with BioFirst dated July 24, 2017 (12)</span></a></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8204;10.5</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1173313/000121390017005978/f8k052617ex99i_american.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Co-Development
    Agreement with Rgene dated May 26, 2017 (13)</span></a></td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8204;10.6</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1173313/000121390017009853/f8k091517ex10-1_americanbriv.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employment
    Agreement with Dr. Howard Doong (14)</span></a></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8204;10.7</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1173313/000121390017009853/f8k091517ex10-3_americanbriv.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employment
    Agreement with Dr. Chi-Hsin Richard King (15)</span></a></td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8204;10.8</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1173313/000121390023025554/f10k2022ex10-6_abvcbiopharma.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8204;Employment
    Agreement with Leeds Chow (25)</span></a></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8204;10.9</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1173313/000121390019001553/f8k012119ex10-2_americanbri.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Promissory
    Note entered by American BriVision (Holding) Corporation (17)</span></a></td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8204;10.10</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1173313/000121390019001553/f8k012119ex10-3_americanbri.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
    of Commercial Security Agreement (18)</span></a></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.11</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1173313/000121390020010040/ea121013ex10-1_american.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
    of Exchange Agreement entered into by and between the Company and non-US persons (19)</span></a></td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.12</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1173313/000121390020009167/ea120625ex10-1_americanbri.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
    of Exchange Agreement entered into by and between the Company and US persons (20)</span></a></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.13</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1173313/000121390020009167/ea120625ex10-2_americanbri.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8204;Form
    of Exchange Agreement entered into by and between the Company and non-US person (21)</span></a></td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8204;10.14</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1173313/000121390020012685/f10k2019ex10-15_americanbriv.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
    of Securities Purchase Agreement entered into by and between the Company and U.S. investors (22)</span></a></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8204;10.15</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1173313/000121390020012685/f10k2019ex10-16_americanbriv.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
    of Securities Purchase Agreement entered into by and between the Company and non-U.S. investors (24)</span></a></td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8204;10.16</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1173313/000121390021015729/f10k2020ex10-17_americanbriv.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amended
    and Restated American BriVision (Holding) Corporation 2016 Equity Incentive (28)</span></a></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8204;10.17</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1173313/000121390021052090/ea148616ex10-1_abvcbiopharma.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Joint
    Venture Agreement between the Company, Lucidaim Co., Ltd. And BioLite Japan K.K.(26)</span></a></td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8204;10.18</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1173313/000121390022027157/f10q0322ex10-22_abvcbio.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amendment
    to the Collaboration Agreement dated December 29, 2015 (32)</span></a></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.19</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1173313/000121390022025731/ea159780ex1-1_abvcbio.htm">Form
        of Securities Purchase Agreement entered into by and between the Company and certain investors dated May 11, 2022 (34)</a></p></td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.20</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1173313/000121390022033890/ea161846ex10-1_abvcbio.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Clinical
    Development Service Agreement between the Company and Rgene dated June 10, 2022 (portions of the exhibit have been omitted because
    they (i) are not material and (ii) is the type of information that the registrant treats as private or confidential) (35)</span></a></td></tr>
</table><div>
</div><p style="margin: 0">&#160;</p><div>

</div><p style="margin: 0"></p><div>

</div><!-- Field: Page; Sequence: 3; Options: NewSection; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="margin: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; width: 9%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.21</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: justify; width: 90%"><a href="http://www.sec.gov/Archives/edgar/data/1173313/000121390022033890/ea161846ex10-2_abvcbio.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Promissory
    Note dated June 16, 2022 issued by Rgene Corporation to the Company (36)</span></a></td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.22</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1173313/000121390023014358/ea174178ex10-1_abvcbio.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
    Purchase Agreement (37)</span></a></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.23</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1173313/000121390023014358/ea174178ex10-2_abvcbio.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
    of Note (37)</span></a></td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.24</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1173313/000121390023014358/ea174178ex10-3_abvcbio.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
    of Warrant (37)</span></a></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.25</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1173313/000121390023014358/ea174178ex10-4_abvcbio.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Security
    Agreement (37)</span></a></td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.26</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1173313/000121390023014358/ea174178ex10-5_abvcbio.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Guarantor
    Security Agreement (37)</span></a></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.27</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1173313/000121390023014358/ea174178ex10-6_abvcbio.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Guaranty
    (37)</span></a></td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.28</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1173313/000121390023014358/ea174178ex10-7_abvcbio.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trademark
    Security Agreement with Rgene Corporation (37)</span></a></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.29</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1173313/000121390023014358/ea174178ex10-7_abvcbio.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trademark
    Security Agreement with BioFirst Corporation (37)</span></a></td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.30</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1173313/000121390023014358/ea174178ex10-9_abvcbio.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Patent
    Security Agreement (37)</span></a></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.31</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1173313/000121390023014358/ea174178ex10-10_abvcbio.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Copyright
    Security Agreement (37)</span></a></td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.32</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1173313/000121390023014358/ea174178ex10-11_abvcbio.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock
    Pledge Agreement (37)</span></a></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.33</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1173313/000121390023014358/ea174178ex4-1_abvcbio.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
    of Placement Agent Warrant (37)</span></a></td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.1</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1173313/000161577416008325/s104643_ex14-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Code
    of Ethics (23)</span></a></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.1</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1173313/000121390023025554/f10k2022ex21-1_abvcbiopharma.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8204;List
    of subsidiaries&#8204; (38)</span></a></td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.1</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1173313/000121390023032016/ea177310ex5-1_abvcbio.htm">Consent
    of Hunter Taubman Fischer &amp; Li LLC (Included in Exhibit 5.1)</a></span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.2</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><a href="ea179866ex23-2_abvcbio.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8204;Consent of WWC, P.C. (filed herewith)</span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1173313/000121390020038891/ea130363ex99-1_american.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Charter
    of the Audit Committee (29) </span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.2</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1173313/000121390020038891/ea130363ex99-2_american.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Charter
    of the Compensation Committee (30) </span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.3</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1173313/000121390020038891/ea130363ex99-3_american.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Charter
    of the Nominating and Corporate Governance Committee (31) </span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.INS</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline XBRL Instance Document (Fiscal year ended December
    31, &#8204;2022) (33).</span></td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.SCH</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline XBRL Taxonomy Extension Schema Document.</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.CAL</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline XBRL Taxonomy Extension Calculation Linkbase
    Document.</span></td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.DEF</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline XBRL Taxonomy Extension Definition Linkbase
    Document.</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.LAB</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline XBRL Taxonomy Extension Label Linkbase Document.</span></td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.PRE</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline XBRL Taxonomy Extension Presentation Linkbase
    Document.</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover Page Interactive Data File (formatted as Inline
    XBRL and contained in Exhibit 101).</span></td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">107</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1173313/000121390023045059/ea179595ex-fee_abvcbio.htm">Filing
    Fees Exhibit (39)</a></span></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.35in"><span style="font-size: 10pt">(1)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current
    Report on Form 8-K, filed on February 16, 2016.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.35in"><span style="font-size: 10pt">(2)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Incorporated by reference to Exhibit 3.01 to the Company&#8217;s Form
    SB-2 filed on June 28, 2002</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.35in"><span style="font-size: 10pt">(3)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Incorporated by reference to Exhibit &#8204;3.2 to the Company&#8217;s
    Annual Report on Form &#8204;10-&#8204;K, filed on &#8204;March 31, &#8204;2023.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.35in"><span style="font-size: 10pt">(4)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Incorporated by reference to Exhibit 4.1 to the Company&#8217;s Current
    Report on Form 8-K, filed on March 28, 2016.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 4; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.35in"><span style="font-size: 10pt">(5)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Incorporated by reference to Exhibit 3.4 to the Company&#8217;s Form
    S-1, filed on September 13, 2016.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.35in"><span style="font-size: 10pt">(6)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Incorporated by reference to Exhibit 3.1 to the Company&#8217;s Form
    8-K, filed on April 7, 2020</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.35in"><span style="font-size: 10pt">(7)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Incorporated by reference to Exhibit 4.1 the Company&#8217;s Current
    Report on Form 8-K, filed on April 24, 2020</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.35in"><span style="font-size: 10pt">(8)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Incorporated by reference to Exhibit 10.2 the Company&#8217;s Current
    Report on Form 8-K, filed on February 16, 2016.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.35in"><span style="font-size: 10pt">(9)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Incorporated by reference to Exhibit 99.1 to the Company&#8217;s Current
    Report on Form 8-K, filed on June 9, 2016.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.35in"><span style="font-size: 10pt">(10)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Incorporated by reference to Exhibit &#8204;3.6 to the Company&#8217;s
    &#8204;Quarterly Report on Form 10-&#8204;Q filed on &#8204;May 10, &#8204;2021. </span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.35in"><span style="font-size: 10pt">(11)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Incorporated by reference to Exhibit 99.1 to the Company&#8217;s Current
    Report on Form 8-K, filed on February 22, 2017.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.35in"><span style="font-size: 10pt">(12)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current
    Report on Form 8-K, filed on July 24, 2017.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.35in"><span style="font-size: 10pt">(13)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Incorporated by reference to Exhibit 99.1 to the Company&#8217;s Current
    Report on Form 8-K, filed on May 30, 2017.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.35in"><span style="font-size: 10pt">(14)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current
    Report on Form 8-K, filed on September 20, 2017.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.35in"><span style="font-size: 10pt">(15)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Incorporated by reference to Exhibit 10.3 to the Company&#8217;s Current
    Report on Form 8-K, filed on September 20, 2017.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.35in"><span style="font-size: 10pt">(16)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Incorporated by reference to the Company&#8217;s Form &#8204;S-&#8204;1,
    filed on &#8204;June 14, &#8204;2022.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.35in"><span style="font-size: 10pt">(17)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Incorporated by reference to Exhibit 10.2 to the Company&#8217;s Current
    Report on Form 8-K, filed on February 1, 2019.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.35in"><span style="font-size: 10pt">(18)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Incorporated by reference to Exhibit 10.3 to the Company&#8217;s Current
    Report on Form 8-K, filed on February 1, 2019.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.35in"><span style="font-size: 10pt">(19)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Incorporated by reference to Exhibit 10.2 to the Company&#8217;s Current
    Report on Form 8-K, filed on April 14, 2020.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.35in"><span style="font-size: 10pt">(20)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current
    Report on Form 8-K, filed April 14, 2020.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.35in"><span style="font-size: 10pt">(21)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current
    Report on Form 8-K, filed April 24, 2020.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 5; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.35in"><span style="font-size: 10pt">(22)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Incorporated by reference to Exhibit 10.15 to the Company&#8217;s Annual
    Report on Form 10-K, filed May 15, 2020.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.35in"><span style="font-size: 10pt">(23)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Incorporated by reference to Exhibit 14.1 to the Company&#8217;s Amendment
    No.1 to Form S-1, filed on November 14, 2016.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.35in"><span style="font-size: 10pt">(24)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Incorporated by reference to Exhibit 10.16 to the Company&#8217;s Annual
    Report on Form 10-K, filed May 15, 2020.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.35in"><span style="font-size: 10pt">(25)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Incorporated by reference to Exhibit &#8204;10.6 to the Company&#8217;s
    Annual Report on Form 10-K, filed &#8204;March 31, &#8204;2023.</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-size: 10pt">(26)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current
    Report on Form 8-K, filed on October 8, 2021. </span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-size: 10pt">(27)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Incorporated by reference to to the Company&#8217;s Form S-1, filed
    on April 24, 2023.</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-size: 10pt">(28)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Incorporated by reference to Exhibit 10.17 to the Company&#8217;s Annual
    Report on Form 10-K, filed March 16, 2021.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.35in; text-align: justify"><span style="font-size: 10pt">(29) </span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Incorporated by reference to Exhibit 99.1 to the Company&#8217;s Form
    S-1, filed on November 24, 2020. </span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-size: 10pt">(30) </span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Incorporated by reference to Exhibit 99.2 to the Company&#8217;s Form
    S-1, filed on November 24, 2020. </span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-size: 10pt">(31) </span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Incorporated by reference to Exhibit 99.3 to the Company&#8217;s Form
    S-1, filed on November 24, 2020. </span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.35in; text-align: justify"><span style="font-size: 10pt">(32) </span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Incorporated by reference to Exhibit 10.22 to the Company&#8217;s Quarterly
    Report on Form 10-Q, filed on May 16, 2022. </span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-size: 10pt">(33)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Incorporated by reference to the Company&#8217;s Annual Report on Form
    10-K, filed March 31, &#8204;2023.</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-size: 10pt">(34)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Incorporated by reference to Exhibit 1.1 to the Company&#8217;s &#8204;Current
    Report on Form &#8204;8-&#8204;K, filed May &#8204;12, 2022. </span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-size: 10pt">(35)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current
    Report on Form 8-K, filed on June 21, 2022.</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-size: 10pt">(36)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Incorporated by reference to Exhibit 10.2 to the Company&#8217;s Current
    Report on Form 8-K, filed on June 21, 2022.</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-size: 10pt">(37)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Incorporated by reference to the Company&#8217;s Current Report on
    Form 8-K, filed on February 24, 2023.</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-size: 10pt">(38)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Incorporated by reference to Exhibit 21.1 to the Company&#8217;s Annual
    Report on Form 10-K, filed March 31, 2023.</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-size: 10pt">(39) </span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Incorporated by reference to Exhibit 107 to the Company&#8217;s Form
    S-1, filed on June 1, 2023. </span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 6; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the requirements of the Securities
Act of 1933, the registrant has duly caused this Amendment No. 3 to the registration statement on Form S-1 to be signed on its behalf
by the undersigned, thereunto duly authorized in the City of Taipei and City of Hong Kong, on June 7, 2023.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td>&#160;</td>
    <td colspan="2"><span style="font-size: 10pt"><b>ABVC BioPharma, Inc.</b></span></td></tr>
  <tr>
    <td style="width: 60%; text-align: justify">&#160;</td>
    <td style="width: 5%; text-align: justify">&#160;</td>
    <td style="width: 35%; text-align: justify">&#160;</td></tr>
  <tr>
    <td style="text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify"><span style="font-size: 10pt">By: </span></td>
    <td style="vertical-align: bottom; border-bottom: black 1.5pt solid; text-align: justify"><span style="font-size: 10pt">/s/ Howard
    Doong</span></td></tr>
  <tr>
    <td style="text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify"><span style="font-size: 10pt">Name:&#160;&#160;</span></td>
    <td style="vertical-align: bottom; text-align: justify"><span style="font-size: 10pt">Howard Doong</span></td></tr>
  <tr>
    <td style="text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify"><span style="font-size: 10pt">Title: </span></td>
    <td style="vertical-align: bottom; text-align: justify"><span style="font-size: 10pt">Chief Executive Officer </span></td></tr>
  <tr>
    <td style="text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td></tr>
  <tr>
    <td>&#160;</td>
    <td colspan="2"><span style="font-size: 10pt"><b>ABVC BioPharma, Inc.</b></span></td></tr>
  <tr>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr>
    <td style="text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify"><span style="font-size: 10pt">By: </span></td>
    <td style="vertical-align: bottom; border-bottom: black 1.5pt solid; text-align: justify"><span style="font-size: 10pt">/s/ &#8204;Leeds
    &#8204;Chow</span></td></tr>
  <tr>
    <td style="text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify"><span style="font-size: 10pt">Name:&#160;&#160;</span></td>
    <td style="vertical-align: bottom; text-align: justify"><span style="font-size: 10pt">&#8204;Leeds Chow </span></td></tr>
  <tr>
    <td style="text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify"><span style="font-size: 10pt">Title: </span></td>
    <td style="vertical-align: bottom; text-align: justify"><span style="font-size: 10pt">Chief Financial Officer </span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the requirements of the Securities
Act of 1933, this Amendment No.3 to the registration statement has been signed by the following persons in the capacities and on the
dates indicated.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 40%; border-bottom: black 1.5pt solid; text-align: center"><span style="font-size: 10pt"><b>Signature</b></span></td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="width: 45%; border-bottom: black 1.5pt solid; text-align: center"><span style="font-size: 10pt"><b>Title</b></span></td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="width: 13%; border-bottom: black 1.5pt solid; text-align: center"><span style="font-size: 10pt"><b>Date</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-size: 10pt">/s/ Howard Doong</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">President and Chief Executive Officer</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">June 7, 2023</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-size: 10pt">Howard Doong</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">(Principal Executive Officer)</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-size: 10pt">/s/ &#8204;Leeds &#8204;Chow</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">Chief Financial Officer</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">June 7, 2023</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-size: 10pt">&#8204;Leeds Chow</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">(Principal Financial and Accounting Officer)</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: bottom; border-bottom: black 1.5pt solid; text-align: center"><span style="font-size: 10pt">/s/ Eugene
    Jiang </span></td>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify"><span style="font-size: 10pt">Chairman of the Board of Directors</span></td>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">June 7, 2023</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-size: 10pt">Eugene Jiang</span></td>
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-size: 10pt">/s/ Tsang Ming Jiang</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">Director</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">June 7, 2023</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-size: 10pt">Tsang Ming Jiang</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-size: 10pt">/s/ Che Wei Hsu</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">Director</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">June 7, 2023</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-size: 10pt">Che Wei Hsu</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; text-align: center">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">Director</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">June 7, 2023</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-size: 10pt">Yen-Hsin Chou </span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-size: 10pt">/s/ Norimi Sakamoto</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">Director</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">June 7, 2023</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-size: 10pt">Norimi Sakamoto</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-size: 10pt">/s/ Tsung-Shann Jiang</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">Chief Strategy Officer and Director</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">June 7, 2023</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-size: 10pt">Tsung-Shann Jiang</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-size: 10pt">/s/ Chang-Jen Jiang</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">Director</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">June 7, 2023</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-size: 10pt">Chang-Jen Jiang</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-size: 10pt">/s/ Yoshinobu Odaira</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">Director</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">June 7, 2023</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-size: 10pt">Yoshinobu Odaira</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-size: 10pt">/s/ Shuling Jiang</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">Director</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">June 7, 2023</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-size: 10pt">Shuling Jiang</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; text-align: center">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">Director</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">June 7, 2023</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-size: 10pt">Yu-Min (Francis) Chung</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-size: 10pt">/s/ Hsin-Hui Miao</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">Director </span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">June 7, 2023</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-size: 10pt">Hsin-Hui Miao</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">II-5</p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div style="display: none"><ix:header>
<ix:hidden>
<ix:nonNumeric contextRef="c0" id="hidden-fact-0" name="dei:DocumentType">S-1/A</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:AmendmentFlag">true</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:DocumentFiscalPeriodFocus">FY</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:DocumentFiscalYearFocus">2022</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:EntityCentralIndexKey">0001173313</ix:nonNumeric>
</ix:hidden>
<ix:references><link:schemaRef xlink:href="abvc-20221231.xsd" xlink:type="simple"></link:schemaRef></ix:references>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrb+OcBO0cz/DPQtq8WT+vHGytpy5eqldqmljvYMs+ffK0hVJun/LoadZRO6MVQWNprQnn57cflcp04FmbVciCcx7O5pbsdx5OAcGWQbAGzERx5qHfCDXZhrqxd/YfiKyzPqxJN9IJ83MFLrhZvySJl383wzLwJ+S9CDoC8LR5NpUkioCs/85l+MU4TtYyP+ZX72G2k8/lxq071isBQFYLB2Yjkp/1Rz27w=] CSR-->
<ix:resources><xbrli:context id="c0">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001173313</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context></ix:resources></ix:header>

</div></div></body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>2
<FILENAME>ea179866ex23-2_abvcbio.htm
<DESCRIPTION>CONSENT OF WWC, P.C
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0in"><B>Exhibit 23.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><IMG SRC="ex23-2_001.jpg" ALT=""></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><U>Consent of Independent Registered Public Accounting
Firm</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We hereby consent to the incorporation of our
report dated March 31, 2023 in the Registration Statement on Form S-1, under the Securities Act of 1933 (File No. 333-271416) with respect
to the consolidated balance sheet of ABVC BioPharma, Inc and its subsidiaries (collectively the &ldquo;Company&rdquo;) as of December
31, 2022, and related consolidated statements of operation and comprehensive loss, cash flows, stockholders&rsquo; equity (deficit), for
the year ended December 31, 2022, and the related notes included herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We also consent to the reference to our firm under
the heading &ldquo;Experts&rdquo; in the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="text-align: center; width: 40%"><IMG SRC="ex23-2_002.jpg" ALT=""></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>San Mateo, California</TD>
    <TD STYLE="text-align: center">WWC, P.C.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>June 7, 2023</TD>
    <TD STYLE="text-align: center">Certified Public Accountants</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">PCAOB ID: 1171</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="ex23-2_003.jpg" ALT="" STYLE="width: 750px; height: 44px"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>ex23-2_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex23-2_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !\ L$# 2(  A$! Q$!_\0
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MHH **** "BBB@ HJHVJ:>DK1/>VRR(<,C2J"#[C-3Q3Q3IOAE21.FY&!'Z4
M244P31,<+(A^C"GT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M^"!W'F.^M"9E'J 1^F:$P.PHJ.">&YB$L$J2QGHR,&!_$5)3 **** "BBB@
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MVLQ.3E>A_*O8/ GQ>U/4KS[+KMO!)  -UW"-A3/3*]#^&*\+C1I) BKN=C@
M=<U[1\-O" FN8HG3,46)KE_5NR_Y]ZRE)K1;FL8IZL]R1PZ*ZD%6&01W%.I
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MI_X"_P#UZZ^BCDK?SK[O^"'-#^7\3D/^%C:3_P ^6J?^ O\ ]>C_ (6-I/\
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MZ/\ A8VD_P#/EJG_ ("__7KKZ*.2M_.ON_X(<T/Y?Q.0_P"%C:3_ ,^6J?\
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M:I_X"_\ UZ/^%C:3_P ^6J?^ O\ ]>NOHHY*W\Z^[_@AS0_E_$Y#_A8VD_\
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M^7\2CI&JP:UIZWMO'-'&S%0LR;6X..E7J**W5[:F;M?0****8@HHHH ****
M.0^(/@>W\::-Y:[8M1M\M:S$=^ZM_LG].M?+FIZ;>:/J,UCJ%N\%S"VUXW'Z
M^X]Z^TJY;QIX$TKQI8>7=+Y-X@Q!=HOS1^Q]1[&@:9\H6MW/9SB:"0QNO0@\
M'ZCO756GBZ!X6%W$RRJN1LY#G^E0>*_A]KWA*9C>6C2VN2([J %HR/4_W?H:
MY4<'KS64H*6YI&;6QHZKK=]K$J-=32-''D0QLQ*Q ]A6>!SBIK.SGOKA8+=2
M[MV[#W-=G;^"5NK)+*!3)?R'Y)%4DEO3'I2<HQLAJ+EJ<EIFISZ9=^;#RIX=
M">&%=W9>-[72I(=0M9Y%N%Y"*N3[@]L5PVKZ1>Z'J4VG:C;-!=0G#(?Y@]"/
M<51ZBB5-2=PC-I6.T\:_$S6O&/\ HS[;/31@_983G>?5FZGZ=*XO!+9'>GPV
M\EQ,(H8V=SQA1FNW\,^#9Y+R/S(?/NF(V0KR%/J33E-1%&-Q?!OA:XN+J"0P
M[KJ8XAC(^Z/[Q]*^C]!T6#0]-2UB +_>E?\ OMW-9WA7PM'H5N9IMLE](/G?
M^X/[H/\ 6NEHA%WYGN*<NB"BBBM3,**** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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3 **** "BBB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>ex23-2_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex23-2_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  P )4# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KD_'&H3QKH^D6[
M1HVJWHMY'E@691'M);Y6X)SMZ^]=97&^+XEG\6>#8V;&+Z1QC_9C)_I0!V5<
MQX^U?5-!\+OJNE*CO;31O.K@'=%G##]1SVYKHQ<0&Y:V$T9N%02&+<-P4D@-
MCK@D$9]C7/?$&Z@M/ 6LM<<K);F%1C)+/\JX'<Y(/X4 6/$VN7&D:?:2:?:Q
MWEU>74=M!&TFU26R<Y /  )K<%<;<1W-OXX\*Z<]TTD<%E<2.-HQ(ZHJ;L=C
MAC@CD9(S@G/9T ,BECGC$D4B2(>C(<@_C5+4]:LM):WCN&=KBY8K!;Q(7EEP
M,L54<D <GV_"N2\&VO\ PCWC/7_#=H'?2HXXKNW E,@MBV08SG.TDY(!YP,\
MYJUX:SX@\5:MXCF+&&TE?3;!&7 "*1YD@]2S< ^@(H [.BBB@#/UW58M#T&^
MU28H%M86D =MH9@/E7/J3@#W->>7%EXD\->'[;QBFJ7NHW^T7&HV,KGR3$^&
M947G9LZ9'8$X XK;^+LC)\-=24(6#M"I(_A'FJ<_H!^-7?$^J6&G?#VZ%[.B
M&;3_ "HX\Y9W=-J@#J<D_P ST!H Z.QO(M1T^VO8"3#<1+-&3UVL 1^AHO;Z
MVTZV-Q=2B.,$*."2S'HJ@<LQ/ 4 DG@"L7P/83:1X+T>PNIFDN4M@[!^&7<=
MVW&>B[@OX=NE94+2^*/B-,6=1I?ATA5BSN$]RZ_>(Z?(.!W!Y[\ '76%_:ZI
M91WEE,LUO)G:Z]\'!'L0001V(JS148GA,Y@$J&8*',>X;@IX!QUQQ0!)1110
M 4444 %<'\29#IDOAWQ#]FN)DTV__??9URRQNI#?F0HY(!) [UWE% 'G4/A/
M6M5N/^$O2]-CX@EE\RWAG#&**VVX6!T]<<DCHQ/?FM2TT#Q)JVIP7/BN]TXV
MEI(LT%CIR-L:5<[7=G&[C)^4<9P>W/8T4 <MXLT?4)]1T;7=&B$VH:;,P,#2
M!!-"XPZY(Z],?CWQ6/I_AWQS82-J4.LV;WM^Q:]M;S=)##R=IBV@'*KQC.#Z
M\"O0:* ,7PYH']AVLS3W'VO4KN0S7EV5*F5^W&3M51@ #@ 5RNGZAXL\*I+I
M0\)R:E;_ &V8VMU;W**&21VD&X'.WJ>3@=!UZ^B44 9>CWVJ7T3/J6C_ -FG
M PAN5E)_[Y&/UK$\>7\]E+X76WN6A>;7;:-PCX+QD,&!'<<C/X5U]8=WX?>^
M\66&LW%X3!I\3BVM53&)7X9V;//R\ 8XH S_ (EV%UJ?P\U:ULH'GN&6-UC3
MJ0LBLV!W.%/'4]JT[/P]I33VFJ3:;;G4DA1?/>,%UPH'?H1TK9HH H-HU@^N
M+K1@/]H+!]F$V]O]7G=MVYQU.<XS7 V%[XA\&ZYK5BOA>[U.'4M3EO;:XM6^
M3$A'#L1A<8'7'?J.:]-HH I:9<7]S;>9J%C'92D\1+/YN![D #/TS4JV-N-0
@:_"$7+1")FWG!4$D#;G'4GG&:L44 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>ex23-2_003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex23-2_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  L NX# 2(  A$! Q$!_\0
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M # 5^E'V:'^X/R'^%'V:'^X/R'^%9_V%F7_15\0?^ \._P#T,!]8A_T+<O\
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M9TK_ ,3;^$W_ ,P%?I1]FA_N#\A_A1]FA_N#\A_A1_869?\ 15\0?^ \._\
MT,!]8A_T+<O_ / :O_R9^:__  T%_P %#O\ I&SI7_B;?PF_^8"C_AH+_@H=
M_P!(V=*_\3;^$W_S 5^E'V:'^X/R'^%'V:'^X/R'^%']A9E_T5?$'_@/#O\
M]# ?6(?]"W+_ /P&K_\ )GYK_P##07_!0[_I&SI7_B;?PF_^8"C_ (:"_P""
MAW_2-G2O_$V_A-_\P%?I1]FA_N#\A_A1]FA_N#\A_A1_869?]%7Q!_X#P[_]
M# ?6(?\ 0MR__P !J_\ R9^:_P#PT%_P4._Z1LZ5_P")M_";_P"8"C_AH+_@
MH=_TC9TK_P 3;^$W_P P%?I1]FA_N#\A_A1]FA_N#\A_A1_869?]%7Q!_P"
M\.__ $,!]8A_T+<O_P# :O\ \F?FO_PT%_P4._Z1LZ5_XFW\)O\ Y@*/^&@O
M^"AW_2-G2O\ Q-OX3?\ S 5^E'V:'^X/R'^%'V:'^X/R'^%']A9E_P!%7Q!_
MX#P[_P#0P'UB'_0MR_\ \!J__)GYK_\ #07_  4._P"D;.E?^)M_";_Y@*/^
M&@O^"AW_ $C9TK_Q-OX3?_,!7Z4?9H?[@_(?X4?9H?[@_(?X4?V%F7_15\0?
M^ \._P#T,!]8A_T+<O\ _ :O_P F?FO_ ,-!?\%#O^D;.E?^)M_";_Y@*/\
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M\A_A1]FA_N#\A_A1_869?]%7Q!_X#P[_ /0P'UB'_0MR_P#\!J__ "9^:_\
MPT%_P4._Z1LZ5_XFW\)O_F H_P"&@O\ @H=_TC9TK_Q-OX3?_,!7Z4?9H?[@
M_(?X4?9H?[@_(?X4?V%F7_15\0?^ \.__0P'UB'_ $+<O_\  :O_ ,F?FO\
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M'V:'^X/R'^%'V:'^X/R'^%']A9E_T5?$'_@/#O\ ]# ?6(?]"W+_ /P&K_\
M)GYK_P##07_!0[_I&SI7_B;?PF_^8"C_ (:"_P""AW_2-G2O_$V_A-_\P%?I
M1]FA_N#\A_A1]FA_N#\A_A1_869?]%7Q!_X#P[_]# ?6(?\ 0MR__P !J_\
MR9^:_P#PT%_P4._Z1LZ5_P")M_";_P"8"C_AH+_@H=_TC9TK_P 3;^$W_P P
M%?I1]FA_N#\A_A1]FA_N#\A_A1_869?]%7Q!_P" \.__ $,!]8A_T+<O_P#
M:O\ \F?FO_PT%_P4._Z1LZ5_XFW\)O\ Y@*/^&@O^"AW_2-G2O\ Q-OX3?\
MS 5^E'V:'^X/R'^%'V:'^X/R'^%']A9E_P!%7Q!_X#P[_P#0P'UB'_0MR_\
M\!J__)GYK_\ #07_  4._P"D;.E?^)M_";_Y@*/^&@O^"AW_ $C9TK_Q-OX3
M?_,!7Z4?9H?[@_(?X4?9H?[@_(?X4?V%F7_15\0?^ \._P#T,!]8A_T+<O\
M_ :O_P F?FO_ ,-!?\%#O^D;.E?^)M_";_Y@*/\ AH+_ (*'?](V=*_\3;^$
MW_S 5^E'V:'^X/R'^%'V:'^X/R'^%']A9E_T5?$'_@/#O_T,!]8A_P!"W+__
M  &K_P#)GYK_ /#07_!0[_I&SI7_ (FW\)O_ )@*/^&@O^"AW_2-G2O_ !-O
MX3?_ # 5^E'V:'^X/R'^%'V:'^X/R'^%']A9E_T5?$'_ (#P[_\ 0P'UB'_0
MMR__ ,!J_P#R9^:__#07_!0[_I&SI7_B;?PF_P#F H_X:"_X*'?](V=*_P#$
MV_A-_P#,!7Z4?9H?[@_(?X4?9H?[@_(?X4?V%F7_ $5?$'_@/#O_ -# ?6(?
M]"W+_P#P&K_\F?FO_P -!?\ !0[_ *1LZ5_XFW\)O_F H_X:"_X*'?\ 2-G2
MO_$V_A-_\P%?I1]FA_N#\A_A1]FA_N#\A_A1_869?]%7Q!_X#P[_ /0P'UB'
M_0MR_P#\!J__ "9^:_\ PT%_P4._Z1LZ5_XFW\)O_F H_P"&@O\ @H=_TC9T
MK_Q-OX3?_,!7Z4?9H?[@_(?X4?9H?[@_(?X4?V%F7_15\0?^ \.__0P'UB'_
M $+<O_\  :O_ ,F?FO\ \-!?\%#O^D;.E?\ B;?PF_\ F H_X:"_X*'?](V=
M*_\ $V_A-_\ ,!7Z4?9H?[@_(?X4?9H?[@_(?X4?V%F7_15\0?\ @/#O_P!#
M ?6(?]"W+_\ P&K_ /)GYK_\-!?\%#O^D;.E?^)M_";_ .8"C_AH+_@H=_TC
M9TK_ ,3;^$W_ ,P%?I1]FA_N#\A_A1]FA_N#\A_A1_869?\ 15\0?^ \._\
MT,!]8A_T+<O_ / :O_R9^:__  T%_P %#O\ I&SI7_B;?PF_^8"C_AH+_@H=
M_P!(V=*_\3;^$W_S 5^E'V:'^X/R'^%'V:'^X/R'^%']A9E_T5?$'_@/#O\
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MK>!_@]J7@K3-<\ ^/?B1X,M=3L- T#7?B5XL\*_!W7]26]7Q9\9] \%Z6_C
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M(_[.WQ7^&FK>&?BSXM^+?PC7X!P_!/QSI_Q)L_@QX)U/PAI_PQO8-8^ ^O\
MA*P^$GP+\'7WBDV#>)/B[X7U33M6\1VMG:P>.4UZ:74+BR\J7R;QC^R;\5?B
M)XJ\6> H_"VF?"?X(>)OC+K7C_Q*;']J/XD_$OP-KWAN^^)4'Q/\7^)M%^"#
M^ _AM/X-^-_Q"\2W.H7Z>%W\>:]\#/A3XUUO4/B?%IOQ@GTT>$O&P!^A^O\
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M \!Z%;)X5L]0O]3U?QQX2L--LKRZUZPBE]4^&OQW\&?%/5=7T70[?QEH&O\
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MA]J_PG^#GQ@U/X1_!O3OA=\"_P!J#Q;^T9\9] \?^&/%-WX9\ WOCCQI\1O
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M=^)=3\:7G@?PC>>,M:TK1]!UCQ=<^&=#E\3ZKH'AS6)M?\-Z#J6NG3_[3O\
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MM9W/V37O!_BKQ-X8UFT,QM=3T+7]7TR^AGM+Z>)_9M8^%WPW\1>&-+\%>(?
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M+6?A]KVF:?/XD_:QT[P=XD@O)?$^B^$OAMJ'P[TNUTKP]H&FZAX9T2Z_:1\
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ML[OP9J.E:OX-NK30[ZQGTVUN?"&K:%HFJ>%9[>WBE\/:AHVDWFD/9SZ=9O"
M?G=^QU\6=2M-3^)7PP^-'C/XH7FM:7'X+^+B^//C7X"^+OP?T>Z_X6]<PZ)X
MT^%_@*?XT^ _AE]J\&_"SXKZ<-$\ +X:LDCM?!7Q$^&7AC4;.[\:Z;JWB+5>
M%T37/!_B;]G]/VG_ (Q_MS_%'X)^,CX^\6>'_$7COP]\7?"?ACP-\%/'-O\
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2*** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>abvc-20221231.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Wed Jun 07 12:51:52 UTC 2023 -->
<xs:schema elementFormDefault="qualified" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:abvc="http://metuboutique.com/20221231" targetNamespace="http://metuboutique.com/20221231" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dtr="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="abvc-20221231_lab.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="abvc-20221231_pre.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="abvc-20221231_def.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef"/>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrb+OcBO0cz/DPQtq8WT+vHGytpy5eqldqmljvYMs+ffK0hVJun/LoadZRO6MVQWNprQnn57cflcp04FmbVciCcx7O5pbsdx5OAcGWQbAGzERx5qHfCDXZhrqxd/YfiKyzPqxJN9IJ83MFLrhZvySJl383wzLwJ+S9CDoC8LR5NpUkioCs/85l+MU4TtYyP+ZX72G2k8/lxq03iD8OBM8362+8OC+Cb4yRg=] CSR-->
      <link:roleType roleURI="http://metuboutique.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000 - Document - Document And Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-types/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://fasb.org/srt-types/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/sic/2022" schemaLocation="https://xbrl.sec.gov/sic/2022/sic-2022.xsd"/>
  <xs:element name="DocumentAndEntityInformationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="abvc_DocumentAndEntityInformationAbstract"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>7
<FILENAME>abvc-20221231_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Wed Jun 07 12:51:52 UTC 2023 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
  <roleRef xlink:type="simple" xlink:href="abvc-20221231.xsd#DocumentAndEntityInformation" roleURI="http://metuboutique.com/role/DocumentAndEntityInformation"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all"/>
  <definitionLink xlink:type="extended" xlink:role="http://metuboutique.com/role/DocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationLineItems"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrb+OcBO0cz/DPQtq8WT+vHGytpy5eqldqmljvYMs+ffK0hVJun/LoadZRO6MVQWNprQnn57cflcp04FmbVciCcx7O5pbsdx5OAcGWQbAGzERx5qHfCDXZhrqxd/YfiKyzPqxJN9IJ83MFLrhZvySJl383wzLwJ+S9CDoC8LR5NpUkioCs/85l+MU4TtYyP+ZX72G2k8/lxq06ic+xcAfV0vXfp09+q1O38=] CSR-->
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentDescription" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentDescription" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFilerCategory" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalYearFocus" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalPeriodFocus" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntitySmallBusiness" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="11" xbrldt:closed="true"/>
  </definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>abvc-20221231_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Wed Jun 07 12:51:52 UTC 2023 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentDescription" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</label>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrb+OcBO0cz/DPQtq8WT+vHGytpy5eqldqmljvYMs+ffK0hVJun/LoadZRO6MVQWNprQnn57cflcp04FmbVciCcx7O5pbsdx5OAcGWQbAGzERx5qHfCDXZhrqxd/YfiKyzPqxJN9IJ83MFLrhZvySJl383wzLwJ+S9CDoC8LR5NpUkioCs/85l+MU4TtYyP+ZX72G2k8/lxq01T8KPOlL+MX9KNCM6LhHvw=] CSR-->
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl0" xml:lang="en-US">Entity Small Business</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl0" xml:lang="en-US">Entity Emerging Growth Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl0" xml:lang="en-US">Amendment Description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl0" xml:lang="en-US">Document Type</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl0" xml:lang="en-US">Entity Central Index Key</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl0" xml:lang="en-US">Entity Filer Category</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl0" xml:lang="en-US">Document Fiscal Period Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl0" xml:lang="en-US">Entity Incorporation, State or Country Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl0" xml:lang="en-US">Document Fiscal Year Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl0" xml:lang="en-US">Entity Registrant Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl0" xml:lang="en-US">Amendment Flag</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl0"/>
  </labelLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>abvc-20221231_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Wed Jun 07 12:51:52 UTC 2023 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="abvc-20221231.xsd#DocumentAndEntityInformation" roleURI="http://metuboutique.com/role/DocumentAndEntityInformation"/>
  <presentationLink xlink:type="extended" xlink:role="http://metuboutique.com/role/DocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:label="DocumentAndEntityInformationAbstract" xlink:href="abvc-20221231.xsd#abvc_DocumentAndEntityInformationAbstract"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationTable"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_DocumentInformationTable" order="1.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationLineItems" order="1.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrb+OcBO0cz/DPQtq8WT+vHGytpy5eqldqmljvYMs+ffK0hVJun/LoadZRO6MVQWNprQnn57cflcp04FmbVciCcx7O5pbsdx5OAcGWQbAGzERx5qHfCDXZhrqxd/YfiKyzPqxJN9IJ83MFLrhZvySJl383wzLwJ+S9CDoC8LR5NpUkioCs/85l+MU4TtYyP+ZX72G2k8/lxq019vK9yj3guNXcNCIbvGsy0=] CSR-->
    <loc xlink:type="locator" xlink:label="dei_AmendmentDescription" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentDescription" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFilerCategory" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalYearFocus" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalPeriodFocus" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntitySmallBusiness" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140038905023936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document And Entity Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information Line Items</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ABVC BIOPHARMA, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">S-1/A<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentDescription', window );">Amendment Description</a></td>
<td class="text">ABVC BioPharma, Inc. is filing this Amendment
No. 3 (this &#8220;Amendment No. 3&#8221;) to the Registration Statement on Form F-1 (Registration No. 333-271416), originally filed
on April 24, 2023 and amended on May 10, 2023 and June 1, 2023 (as amended, the &#8220;Registration Statement&#8221;), as
an exhibits-only filing to provide an updated auditor consent as Exhibit 23.2. Accordingly, this amendment consists only of the facing
page, this explanatory note, Item 16(a) of Part II of the Registration Statement, the signature page to the Registration Statement and
the filed exhibits. The remainder of the Registration Statement is unchanged and has therefore been omitted.No additional securities are being registered
under this Pre-Effective Amendment No. 3. All applicable registration fees were previously paid.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001173313<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">NV<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of changes contained within amended document.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>ea179866-s1a3_abvcbio_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="abvc-20221231.xsd" xlink:type="simple"/>
    <context id="c0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001173313</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <dei:EntityRegistrantName contextRef="c0">ABVC BIOPHARMA, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c0">NV</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFilerCategory contextRef="c0">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="c0">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="c0">false</dei:EntityEmergingGrowthCompany>
    <dei:AmendmentDescription contextRef="c0">ABVC BioPharma, Inc. is filing this Amendment
No. 3 (this &#x201c;Amendment No. 3&#x201d;) to the Registration Statement on Form F-1 (Registration No. 333-271416), originally filed
on April 24, 2023 and amended on May 10, 2023 and June 1, 2023 (as amended, the &#x201c;Registration Statement&#x201d;), as
an exhibits-only filing to provide an updated auditor consent as Exhibit 23.2. Accordingly, this amendment consists only of the facing
page, this explanatory note, Item 16(a) of Part II of the Registration Statement, the signature page to the Registration Statement and
the filed exhibits. The remainder of the Registration Statement is unchanged and has therefore been omitted.No additional securities are being registered
under this Pre-Effective Amendment No. 3. All applicable registration fees were previously paid.</dei:AmendmentDescription>
    <dei:DocumentType contextRef="c0" id="hidden-fact-0">S-1/A</dei:DocumentType>
    <dei:AmendmentFlag contextRef="c0">true</dei:AmendmentFlag>
    <dei:DocumentFiscalPeriodFocus contextRef="c0">FY</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentFiscalYearFocus contextRef="c0">2022</dei:DocumentFiscalYearFocus>
    <dei:EntityCentralIndexKey contextRef="c0">0001173313</dei:EntityCentralIndexKey>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>12
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MSTQ6GK2D54YZ>GPKPH*"K&&217"7::YWL,C*;%/4;GJ:C!C17E@!3DO X!U
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M%]0+R?*94 ZTR&UKOA*:&GW[&=/3"J41H/6UH-NC&A@#]6-M_"]02P,$%
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M$MP>:4#M.*2VBZD8_1!2:5K5N %(MB6/:<Z10J[4+!XUA]) 1-MC0[!:+#Y
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MX_T,:3?D@6)8YL_X>\87_QO.\1'"[K\_L;S63AI_YHOA/UY_ 5!+ 0(4 Q0
M   ( /%5QU8'04UB@0   +$    0              "  0    !D;V-0<F]P
M<R]A<' N>&UL4$L! A0#%     @ \57'5E^.$WSO    *P(  !$
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M;',O+G)E;'-02P$"% ,4    " #Q5<=6.JJBYT !   \ @  #P
M    @ ' $   >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ \57'5B0>FZ*M
M    ^ $  !H              ( !+1(  'AL+U]R96QS+W=O<FMB;V]K+GAM
M;"YR96QS4$L! A0#%     @ \57'5F60>9(9 0  SP,  !,
M ( !$A,  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&      D "0 ^ @  7!0
#

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>11</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="ea179866-s1a3_abvcbio.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://metuboutique.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="S-1/A" original="ea179866-s1a3_abvcbio.htm">ea179866-s1a3_abvcbio.htm</File>
    <File>abvc-20221231.xsd</File>
    <File>abvc-20221231_def.xml</File>
    <File>abvc-20221231_lab.xml</File>
    <File>abvc-20221231_pre.xml</File>
    <File>ea179866ex23-2_abvcbio.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="11">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "ea179866-s1a3_abvcbio.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2022": 11
   },
   "contextCount": 1,
   "dts": {
    "definitionLink": {
     "local": [
      "abvc-20221231_def.xml"
     ]
    },
    "inline": {
     "local": [
      "ea179866-s1a3_abvcbio.htm"
     ]
    },
    "labelLink": {
     "local": [
      "abvc-20221231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "abvc-20221231_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "abvc-20221231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/sic/2022/sic-2022.xsd"
     ]
    }
   },
   "elementCount": 14,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 5,
    "total": 5
   },
   "keyCustom": 0,
   "keyStandard": 11,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "abvc",
   "nsuri": "http://metuboutique.com/20221231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea179866-s1a3_abvcbio.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000 - Document - Document And Entity Information",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://metuboutique.com/role/DocumentAndEntityInformation",
     "shortName": "Document And Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ea179866-s1a3_abvcbio.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "abvc_DocumentAndEntityInformationAbstract": {
     "auth_ref": [],
     "localname": "DocumentAndEntityInformationAbstract",
     "nsuri": "http://metuboutique.com/20221231",
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description",
        "terseLabel": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://metuboutique.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://metuboutique.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://metuboutique.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://metuboutique.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "localname": "DocumentInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://metuboutique.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "localname": "DocumentInformationTable",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://metuboutique.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://metuboutique.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://metuboutique.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://metuboutique.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://metuboutique.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://metuboutique.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://metuboutique.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://metuboutique.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0001213900-23-047063-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001213900-23-047063-xbrl.zip
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M)7T)V4O=/([;Q+=!K7.1$Z D>,]K7@VX48[7O@LW&F_6H>&;%ITW;ODI1TP
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M@W]8_U\@@!YC@[PH3B:3(VAC3*A39)(1A<CD#X @V(0NI4P1)\R#!YNU/#*
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M@8FNQX7M^_'H4+KZ?R!\^P-02P,$%     @ \57'5OW!NCZO(0  ;F\! !D
M  !E83$W.3@V-BUS,6$S7V%B=F-B:6\N:'1M[5W[<]JX]O^=OT+?W-D[9#:
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M!L09?]K%3H=_&+R9&J"AL:2SW\]AW,,CH\\,NU^R7! O0S3<8CR()(&]F*;
M>4$OAW. \;^3:[5:@;_UBRXNQ&;.'IM!!.O'&<3^.7*I:Y!C=%00?\EDCF >
M8:19IDM,F"\N&;H%_B&?S#GRTZ/W;_<:XGWN!L9W#Q6@TH*H]:ACZ:/C(YW>
M(\<=&>3M7A>*'B)9&KCHAO:)@R[( [JV^M@\$ \.4)O8M+O'OV(4%-C_CP;/
MK> -ZF/[EIJ'B!65WB!&>PX;]!8>:4 ML:&-SG'=05UJ@)QYH&X/N3T"GVN>
M35T*=6-31\VAUL/F+6%RK4\=)@TSELG$$D&5 RZ*C@J=XZ/"8*TDV_2VYW**
MK\DM=4"D,%F"+JP\4E4UIU3DHEQ>#R%[$74R,7U&B0%"^MHS2.X*PPB!1 [S
M6E22<ZT!KRBH-=>Q7-?J^\\>J.[V&%'2'WMS2,DY]!>!EZQ@Q[)U8HO:3@RL
MW2$%B',L@^KCET'-XKT<O-\[_O>_Y++TQJ=]K@>%N2ZL=_#6 ^:@C_&T!D!L
M-QM?KELWK68;U2].4?-[XWW]XET3-2X_?6JUVZW+BS@F1HB@;]CI@77B6O#]
M:;Z1A\E9*M;B)")V'EQ=-W/-L[-FXZ;UM8GJGYH7I_#?#;JX!+F ;BYCYL#9
MY?4G=.0,L!FTP.RC'!WF>E37"106_\]UL>;F8'*T<_)1@95G6F>+^73=?-=J
MWUS7;V!6H/9-_:;)V+3573ZBQU\N3IO71P5Z'#,,H>F;]TT4%E"-&W1YAN2:
MJL9-3\P#3X>'IF5>>'WX1!.FV]"])MVW>QIX<";N0XO@)QPV33#R1H$Q8;H7
M\$981"=?&^BD=7GUOG[]J7Z 6A>-O!BOJ:KCY&>V.01YP8E'5A?98Z(1=I S
M(!KM4C#AJ(FHZV3 7K/AR_TT,-G%'8- *<,88%VXSL %]AN$GA;\?C9%(:MI
M;/QHEF'@@0/V4O"W/1"JKLW^T(,FP)]WJ8:-@'XPI\:UJ<H?<Y941UA2^=+$
MUGH!ZH3O^W;/]Y</P9MQR<"V[AE'B3D/RY:I6?; $D9NFY5N6)[IVJ.&I3.4
MAC5,V%"$H>. N2#W6,<" %R[S(/7U9<.C!B \=BPH5G&]T=J6]4P/];ODE0M
M3O5Z*WNIE'/@'Q?+I>IL7^$/^XF@?U'+68Y%9-G( E?11O^ I^CH5..^F-4]
MZMB%8Q!#(?#RLO8M-NDO_GO_)>QY+4]>UM<KFX+D&R'HLZEC6T<M4_= [E)L
MB(XV# S^<!>:XSUE<Q/!!.N,96^<O=Q;I_YIY:_S[3QJ]@>&-2*VZ'X+#%EW
MTOVIG@^F\%C@:L!7#=MD;'2.BT6U(J%+0T??L-U'[8$-2LT!#_Q>SQ_$:M,S
M]\,F?:CR #7JJ%8LJ=68V\^69&D?E<O5G%2MRG$W7M=UFSCP&0@@PV/&!OI%
M!Z",=7+ 0UDN,<B@9YDD8W*LADMBFV"_Z)2%]>]_516Y\L9!C+$:'6 #D2'1
M/)?>,UL,T$^<_>WVW4[M/'IO/3 )>&I9YFW,?&WT*.FBYGC0+_F@VW'/K=U$
M7SC1<Y.9%3<=S&N#R;VZF8]OH79FL".'V/< M"V?W$?T^!N+_&O6@$7\7>LP
M=?&!^8_>H.=2L#0*SP?BW/*H@VZPU^&5-)V?^96-0E0/GDK7!PO,U&_>DRB*
M8Z0>,YO?>ZS=C#^0Z(PZ&O,4_HW[8(B?4W1^WI@RCE/=F5I)RMST*&B^^CTQ
M/1 1<@TFRYEA6?;F] *JS_RP[+L#WA#[&V)FC51\(TN2HFQ.1[(UN;*?*<D*
MJ!VE,J=V-J$+7,QD(L3,+/';H&?^ 7>9=D<BK#H8V-80/&J7()T'$;J@=/I]
M8FJDSW0N_(82 \LA>L;!!B_ UJ.=R7JT:_$G Z]C4.V0*^:Z@QPP2ED@=&!C
MC7G%+.*(N]!-* PBW0ZO%_/(&V\.WNA$,T#[ZXATNT1CQF4^MA&)F0$ML&S,
M4<20=@BS@<08$386EIGAPW;&,I=@=-B@=[BKX[]&& ;.P"/VP^:A3FIZE@=5
M80>^&WBVX['0-'S'UI5142XAS]0Y.Z:R"^H:9SI;DSA H"2T.UZB:QF&]0!4
M93K6,(_F9U07]ZDQ.GPL@>+?_ZI5BN4WCXN%36?LA%TT2.: L0]8RHQCRK"/
MC4R([\S"Q:9@*T/ /-O*2K:SOY!S!VA@$.R0*,8A8!PWNPV@(.+;S((I*6SS
M *0$VP:%G^/)N6@FLZYP5(OE$=&AUP*G^+L!!R,0O6YN,MHPFJ8N!IAA*A.)
M$&T90EX C44\'D,CLX/&AD!#WT%C"Z%AZBS>3UBBL^ A?'6''GJ$KP>Q 9W$
M3C,<.V!BW0)D- V,=9$DS4!CL\!,Y%-D6F8NXH73QP;\!>H?6+;+ ,.R;<&J
M.4!"EP%?60=NT:UM/?"0!G^=S[0)X93II$M-K@L=IF28#Z1(;Q;1QU_+;X)B
MCQ982)]?+L.P[9==0&I0(S7%-)*53DX)].$X$1/FPAKLU%2OX2]=]PHOC 4+
MN:4_'O/%SJ/9CA:MVBVO^4E"0GB;4U3,2HUG-1JNJ)[&C@2KT8^R[S&_^7GI
M%83G4/!18++JUK)'44D69ZQ PR^P=WP1)79F\R;F1G750UB>P\(C8]->)'8B
M2'WR,!YVZ9#H.=?VR/RX\19//(>:Q'%6CJ'0 $2FK#P=4S-KYW._EX]K,UI$
MKV!4N]AP(H8U:/ =;Z\AFEOG%%TRO.M8L$\FYK'(*F K0#.F3(:;,K0[8\6@
M'G802 6-"073XD:NYPB+ IH%2Y@YW&R+$S<MT  HM'1N7[*VC!%KG.^N8/ Q
MH4<6FZWWU.%"QL2F1K'!-!%+\6)Q#\=/.&$A+>N>LOK#%G:;B'R;2A;O9Y7]
M[,E^8"),&\PI-F:3"$#>P !=A[A*; *<YZZ,,Q\IS$P\!>8V>%K/CUK:_/\.
M"SCV\8B%QDRB@2!DF4+ '!X:8VF8(0^$?\AX:W NA8AP>B!*N:8!N[?KV=R(
MGGA7;@^[&3^_$T2<,1+^B\-?+(UNBHI9=42$0CL$P$A"1%%N?8/9Q396"7P&
MP*H"L.8AE9F*UT'W.9U$Y^;WI'=+"9JC8FILL?/$#4@'&1;IG8E:.9CJ4UTX
MX S2"72_#[IJ=<MY*?3+TKE#:;P#:<$.I?$.IB1W*,7,P$=XQ?KX!C[\Z;&%
M$:A_TF&^15%\L("'LA+!Q'*(-S,;Q":9J.'LP1"Y4\,P;GH1*1T0-G>Y#@'5
M!Y0/>$_"Y)4CJ&,DO[SQ,$36M7\M]I2,YO>K\_I%_>;R^@>ZN+QIKFM7XZ*.
M+;=G_04?HM?!J/V['NBJ4^)H-ATPX9O3I+]9J;_EL)$;57+E.:OCV2LV<5#K
MJH?!_#Y +5/+^\LC3&]PU3FF*,-WD:(L?^I':,8OQ193/S*S'RQ!3FU";8=-
M!1XT/<O)*+MDH^H^4YH4>L&5N@BB0J'ZP 8MJA3%MEJN_7PERVK^!-I,ED+O
M^!Y<V7^0#6MD1J+?D6A*@_X<"!OQ&#L99BL/>[0#MDO.,@59?*RLP QEYK0W
MT+EWC#V=NF+]SR%B(TI3?(T4-:_DP0!EQ@548(P.Q'A/[!KV$1#E(-Z.;VET
M>2PIP\2&_P$9#@QL8FAFQ QO>-P"ZI%<]NV3*VR[J-4**HCNJ1@,!^"!7<\F
M7"P]PD486QY+%FMIP:#DT0TW;_J8\K#VTE89UCQ3&"XZ9U9/6#<VEXY@"!$3
M67WJPECFPV;VK%>6I*H#4OS9+GI']<=G_-J(O+!"*YGA%6S,AW-Z%3L3K#P
M&ZYLDFN.#<Z9>0TX!;,4#P:&GS@P9;YV"=3_0!AJF,-F>0[ =0!V9G[,J_
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MWM"SYI3T'\//^%>KELL@$-29%9F@@AQ (P>5V%AS#X.\E34("A\O?&G@6^,
M7>4;>905Q]FRN_B86_T4W1*Y:KZWCL&OU1*4%:O9\J!6JS6>; <3NJR*X^+6
M=](.Z!F0 8%$8(OB=78UI;@MVG4)RS.O[:.7,ODY(F"U,$ANFJ\-!DJ<,&"Y
M$<1T1)0LA 95>CD:UL7KY/9OKHW7:IR\OK#ZU,3\2GB6Q!C$1PEZ9P$?37[%
M?1@"\L8)!'9K5>NBG2!.5M9(RS2H2=#WD^MSU#(=EW/GU-(\$:IA5APVT(A@
M&XE+<((L?4Z+*A\$1T@SKX.EEJK[^4<,N?@F,^-3N_%^V_AT@X>6:?5'8$&[
M(%3Y7<=@:_?QF'$O8D&"DZE1/_\-F-3 AN890@>>4_.N@_TL\%>Q;6U,.6V>
M_09,.25=:M(5\R3!J71>/_D-N':..\08,RRE$^CJNOD;L.+*)LRM7[582VP*
M)7?PQDHC]S"H?*L(6'5@GV.-[_(^!:<!G5$#S&ZQBX@ENF,'"19S.CB;^5XY
MJ!/#TZE8'< Z5?9=<CN^TQ:N+9:D4HV':VNE6HD,<UU"9K954F#R+:?_C "!
M 4^S:FUQ_#78$/8[7@^^-(H\&X;UJY;R:HF:41YVF./AZX9?OCPP+:2#.\+$
M+A7 $['Y=C#7"LW>O#RS6V5R19!GVT$T_YJPW8S\CC&0$JB:^W@0=>V8?\%#
MM#Q8NI-P!Z)5@$A)!$1J7EH(HG&:0/LDITP@P[=2*?RN;4F)#2V_+S#41(#A
M!X+4O+( 'F(O@6EZV)@5,>,C.'+^W\(2QW_D7WDY%7)2XQ,^OR^<BHG J;@"
M7>7?T%R-6U$]88/\BVM^UG;ZXF[G?-3.>66;=\[OY-LSY5LI(3NJ^+@9E9-#
MTJQ-!JXX(4E6TR/1MAT=Y830\;B1/:WKZ@.;&DA<!2WM<+%V7%22LXI>8Q()
MF(B;TG8XB0$GU:1"/<K&QGE^7[#4$@$+RW-\M:_%@SRU'51B"R%+R49YRLNB
M/'ZISQ[/#C-&L]"9!'H^1\1Y0.9(X2B/G$<[0*T?4,DL2JQ$^(R5E>+?$KR3
M0#$ )ID%B)6L8DW=%[P#2PQ@26918B72A6DD5=IA)3:L)+/BL!+!,@G2*3O$
MQ(>89&*X[$" '6(V$S'QQG47!7(#+Z<=^$/R 2=EUBD2I]$6I[9;[& 2 TR2
M"?.*\-W*,K6X6*GM\!(#7A(+][Y>$>WPD@!>DHGXKD2^B*4DV5]*VJ$EAHS/
M9&*^KW>,=E")'2J;FF(^O4"=!JC$G+-7VN7L1>7LJ;N<O9UXFXBWY-8>2HOD
MFTAMCQ)OLC21;WQYLY0>Z;;U2$EFX4%>DK\^?3GFA25*<J1,9WQ>6/=^PF=Q
MEU@1&V"26WU8E%.Q$RWI1$HRJPZ3^XJ7YN!$[[0*X^7Y&ZN>.)Q1YR&'GSV[
MOL<8D4R2]DH6#"\UUV(BGF]26ICJE-:!CS<\OFPA9:(Y.16SJ<X;!NC$PLAR
MY;4ZB D3_]Y$.5$MM%8'?AUU;KB^7'1I^"-0#Q\(FI+,H 4;L,;F^#@Z]2IA
MO;2'S[U1X!7"Z!4C/7V 9[S<6[B L>/>D[DG)\:]A<N5K^3>[MR19,2XJB0#
M)7Z]\2(LC?<?++!:/L\D>0;7/>\D@QIOU&RQO3G#-4[(O+VY2N=U*]B74 QK
ML4D57 *PV"WV2U3GCH!A,S.(>2B[">IS.+&,UQ5M%51DGY6_/2<3"UZ]/@5H
MQ\DI3L8<#5O,N0G7.!%+=\RM(CZV%=Q+)N:F+%&:SPFYJ?*.CX*/"0649&EA
MZ'2!3RN2^GVVI6&+\YH<Y6>E/Y5WZ4]1Z4_%7?K3:^,RJVU.,!V&IW/<;KV[
MJ-]\N6ZVCPJ=-:P5)-K/<7-7GNUX[*)77\C9@$%J\YM@G>#N'_]29DJ<3%WC
M5[W)-54]\,O?4L?E5\7VL(-TM@-;PYX#LM#MT5!6#,N(0>JD&?$9/U_><4$$
M\S*!(@2)RDIV"'* 7"%7*1#4(3UL=#,@K%DEG@DB0!3@Q-C$,^$K3@/VW)YE
M@[3G)YUS\<VNE0;:;S =$"IN,?(?O;?,6_01_C@8"_#*6.\FS/=4Q!V7+IFR
MTDS)O=U3'E.Y,*WJ)U\;Z(1:5_SZT@,$6C@O)EBD@;,HJEEF=#_7H/&_+;W\
M4_4IWRXC_[GM1IZ[_P)CYV1TN-1^FFU':(LY/=N9U;,O(J;@%&#./6!;K.J?
M6C#UGLK_I :0JV[1SN/7=RX:S1>T*\9I,\;HAKH&>1G.7M!:HT=)%PQUT$[\
M'HS+;I=JQ%X41(QQE)Y1R=+^/R)3DA?&J_8H7^&!IF82I$[2!E=Z$Z)/G>/5
MZ%D/R<^5=$K=\)@A-E ID"KID[UGE%W\2;&Q7/:F8/4^E=[3K'OTF'?$'*P.
M(6;@%/EN4!>,=>N!W<PZ '?(,IW X]$P\Q!8R]S;L?C3C [5L2(Z0,$E^L[#
M>7%F13%4\Q/%]CB^\)AF;D-Q['HVF57'"VB1_XANZ'&7IEA:7R^X4%I[#V1U
M?3TXA3FRQ")Z<=S[";U+VKAZ)ODO'95U,&[B8,X[3FL9MN7DL-L4J<Y$.(\Z
M1?LMZZ+Q:2,6#GJM"^LO<W03X%?VRJ9@UPS L)ECT_.7$^.?4CM!$Z>@F?(5
M%OA6"8!X@8G^NXN9.<\N/;)FPBNF)NJ:9GFFR^SZG>A)G^A94USGZ6*GZ=T2
M_WK?#Q0#2I[C^J\D=OG24$6CAZD-'EO@(9]83/'#CU/PG377LIWDN[(IXDR@
M0"!@%>)A _3X;R-B4F'=W#A,MGQB:FAE('N%N@Q$Q.]NQL3.EO3/@)U<B%,N
M-$!Q?R,4O7>\G4A(A4B(DR/IQ_U.&JQ.&JQ['';S^RD4_"!F[KU#31:U\)Z?
M#+]]8-Y-\3@5_H5ETSY%;7R'^Y9K[91^*H1"W%Q)/_YW4B'>\(!GWN;:/6R:
MJ8@/B%6/-DN>(;>C<5X2"ZCO1$80.HB;9>F?'CNA$6_L %"7^T#2(3)V<F&\
M+!,K5]*/_YU4B%,J_+"<'C6MCH<N=4QMO!,+J1 +L;,E_3-@)Q?BE OMGF?L
MEA_3)13BY4GZL;^3"+O5ANV:X3^\W"=JHNR9S7(2G7UPVKS=5-]-];AW<3C4
MS+WW*/I$<5K6'-:V]K8ILB%>IB0 _I7N6%UZ=-1R%;BRG9D;2D.KE2LMH6#^
MDS=HI50]<LK9M6>07/@4K("P)W4XM$%U;^KK\'P+G77&:XLXZ"Q@%*=N_I2N
M.2+7>]W%^LZQ"XV03IV!@4>'R+1, E30X6&/8!BD8X0R_!?5=6(&OZ#4A=>'
MQC2D 56 FFO2?;NG27N(ZF_W1.%<%VMN#AZ9N,^:(/3PU-(\MO.:'>(&/D].
M+M2/"E/U'3_:P*2V\5[O,P/?[AV[MD?F:GM&=0%Q9]0!"7\%I2W]#)XY>\=G
M/U97\0^";;]:=ASL:RINFBYU1PVHVL9&R]3)\",!>2U)DBQ75%56(P:W$&:F
M:&M\3J-S? 1.Z-VAH_5('T.#:,A_]VS6-N[<:SE&LJRH<G[HZ'O^:Q>X^7;/
MH?V!P;!3F*[CF#<9:@,:9=/IO]\^?2W][[_?M8$W_&&6:OJOROWMCY'YY=1[
M>%>Q:Y6/RC]?;D:.4;G7?DG&![?@MLF'7Q7U;BAKYZ[TU]F9TOY8N!^>-'Y(
M]WK;[OQYJ9U<2MJOPNG59_=G]=O-G_?OWXW<P:A$?AKZS[[QS_V/3\Z?W>Y'
MJ?<5E'[AW,+Z7]>7Y4]?/W^[&-B?3;-4T;J&-I"*9_W.5XTVM&'ELC3H./JP
M=%G7WGW[W*F_^]6\'I9^ON\V3K__U;-_#O7"CR[]./IU]7/XX:+6^E!5/YV=
MV[V_[D?M#X9:51]^G3]\^+-=:YQ:C>KY=>EB\.6.6@VG4"T9?W[Z4KQQ?XRN
M_OSK>T5YI]Q5"\;PIU21J7/R^>S'^8GRXY^[04&^_J54'M[^#S7:UR!T K8Y
MEF=SK@T[MD$/?:#P*0A X?P%W2M>$HZ58_YH_)#OH:5=2L# 8?P"-O9<=W!8
M*#P\/.0=HN5OK?M"H_5Q&E2S'[.6>%.%F;9"[0_X?)IIWW&Q[;(=X7PJY"09
M_@TJF;Q#?O6AONB3CV0EI\J3EL6;,#7CEAGZIT8J@.9X' MAN0?E,U-*H-"Q
M]!$S7WINWSC^?U!+ P04    " #Q5<=6_A#WC7(#  #:#   &@   &5A,3<Y
M.#8V97@R,RTR7V%B=F-B:6\N:'1MY5==;]LV%'T/D/]P(:!! OA#MK(&K14!
MLNRT'IS4L-45?1HHBK+82:1*4HW][W<IRUWK!$62+1N*^<$2J?MQ>'CN%>6_
MC:_GP?&1_W8:3O *]N?'LW@^#?S^[HI/^^UC?_QN\A%6\<?Y]-+)I#"O8>!6
M!F)>,@TW[!:6LB2BLYOHP(HIGCGHB*Z+Q_J-H"1JS<5KL*;N" S;F"XI^!JG
M%%_GIIWB(F4VI,N%$_CC8+K)><(-#+W>T.^/<2&+OPFA:V35P/@ZD4AC9-G.
M?0N,(A2F&APG(M'5Z+]$X,^NW\!J&5TZ;#/TNL/?77?0^U2M'0CG\:6#-O]C
M>MX'D10:1R SF*&&*M8("99LS37:L!06=5)P"B&ELA:&B_7QT157I=]__P^
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M     &%B=F,M,C R,C$R,S$N>'-D4$L! A0#%     @ \57'5DE28F#H!
M^QD  !4              ( !E 0  &%B=F,M,C R,C$R,S%?9&5F+GAM;%!+
M 0(4 Q0    ( /%5QU94MWU<; 4  %LI   5              "  :\)  !A
M8G9C+3(P,C(Q,C,Q7VQA8BYX;6Q02P$"% ,4    " #Q5<=6(,4R99H$  ">
M&0  %0              @ %.#P  86)V8RTR,#(R,3(S,5]P<F4N>&UL4$L!
M A0#%     @ \57'5OW!NCZO(0  ;F\! !D              ( !&Q0  &5A
M,3<Y.#8V+7,Q83-?86)V8V)I;RYH=&U02P$"% ,4    " #Q5<=6_A#WC7(#
M  #:#   &@              @ $!-@  96$Q-SDX-C9E>#(S+3)?86)V8V)I
;;RYH=&U02P4&      8 !@"7 0  JSD

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
